As of 3:27pm ET
| +0.01 / +0.37%|
The 4 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 4.75. The median estimate represents a +101.47% increase from the last price of 2.73.
The current consensus among 4 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.